Precipio, Inc. (PRPO )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol PRPO
- Company Precipio, Inc.
- Price $7.14
- Changes Percentage -7.27
- Change -0.56
- Day Low $7.14
- Day High $7.99
- Year High $10.74
- Year Low $3.9
- Market Cap $10,780,351
- Price Avg 50 EMA (D) $6.78
- Price Avg 200 EMA (D) $6.22
- Exchange NASDAQ
- Volume 4,075
- Average Volume 12,426
- Open $7.7
- Previous Close $7.7
- EPS -2.93
- PE -2.45
- Earnings Announcement 2025-05-12 20:00:00
- Shares Outstanding $1,504,312
Company brief: PRECIPIO, INC. (PRPO )
- Healthcare
- Medical - Diagnostics & Research
- Mr. Ilan Danieli
- https://www.precipiodx.com
- US
- N/A
- 06-30-2017
- US74019L6020
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.